Today on Outsourcing-Pharma.com   Oxford Genome Sciences advances on Amgen deal Siegfried and Arena sign contract manufacturing deal Pharmaceutical contract services round-up French CROs have eye on niche market Patheon reveals plans to tackle Puerto Rico problems

Related Industry News   NIH cash for new tools to unravel genome's secrets Semen fibrils ferry HIV into cells Biogen Idec shares nosedive after withdrawing 'for sale' sign Roche targets Ventana's board to force takeover

Breaking News on Outsourcing Pharma
Daily  Tuesday 18 December 2007		Forward to a colleague

	Sponsored Link Almac improves IMP blinding services Almac Clinical Services now offer enhanced encapsulation and blinding services. Almac provides fully automated over-encapsulation for capsule batches of hundreds to millions and also a range of blinding options for inhaled products... Click Here Access Full Stories Oxford Genome Sciences advances on Amgen deal Oxford Genome Sciences (OGeS) has taken a step closer to shedding its service provider skin and morphing into a pharma firm after entering a new cancer collaboration with Amgen, one of the world's largest biotech... Read Siegfried and Arena sign contract manufacturing deal Siegfried has signed a $27.7m contract with Arena Pharmaceuticals to manufacture Arena's Phase III oral obesity drug candidate lorcaserin hydrochloride... Read Pharmaceutical contract services round-up In a round-up of motley pharmaceutical services contracts, Outsourcing-Pharma takes a look at recent news involving United Drug, Movianto and IBM... Read French CROs have eye on niche market Two French contract research organisations (CROs) that specialise in ophthalmology have banded together to offer specialised services to this niche market... Read Patheon reveals plans to tackle Puerto Rico problems Patheon has finally revealed its plans to tackle the ongoing problems it has been facing with its Puerto Rican operations, which are draining the firm of profitability... Read
	All News Headlines for: December | November | October
	Sponsored Link DPT - The Industry Source for Semi-solids and Liquids. DPT is a contract development and manufacturing organization (CDMO) specializing in semi-solid and liquid dosage forms providing solutions from concept to commercialization. Click here to learn more about our services... Click Here
	Related Industry News NIH cash for new tools to unravel genome's secrets The technology used to decipher an organism's gene sequence has come on in leaps and bounds this year. So much so that the US National Institutes of Health (NIH) has now released funds to create new tools to analyse... Read Semen fibrils ferry HIV into cells Tiny protein fibres in semen have been found to enhance the ability of HIV to infect cells by up to 100,000 fold and could provide drug developers with a potent new target to tackle the virus... Read Biogen Idec shares nosedive after withdrawing 'for sale' sign Like countless pets after every Christmas, it seems that nobody wanted Biogen Idec after all; the firm has announced it will remain independent after it 'did not receive any definitive offers to purchase the company'... Read Roche targets Ventana's board to force takeover The latest twist in Roche's long-running bid to acquire diagnostics expert Ventana has seen the pharma giant announce it intends to elect directors to Ventana's board at its next AGM (annual general meeting)... Read Weekly Comment Paediatric drugs and testing highlighted The importance of paediatric drug formulations and clinical trials in children was highlighted at this month's American Association of Pharmaceutical Scientists (AAPS) conference in San Diego. Read Sponsored Link Introducing Catalent Pharma Solutions Catalent Pharma Solutions is the leading provider of advanced technologies as well as development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer health companies in nearly 100 countries... Click Here Previous Headlines ClinTec to take on India UK contract research organisation (CRO) ClinTec has outlined new expansion plans into India to try its luck in this country's burgeoning clinical contract research arena... Read Japan says Tamiflu/psychiatric link unclear Any link between the antiviral Tamiflu and neuropsychiatric problems is inconclusive, according to the Japanese Government... Read Novartis launches initiative with 2,500 job losses Novartis is to sever a further 2,500 jobs as part of a new initiative aimed to 'improve competitiveness in a dynamically changing healthcare environment'... Read China's API manufacturers facing further crackdowns The first steps in tightening the safety controls on the pharmaceutical ingredients imported to the US from China have been taken following months of negotiations between the regulatory bodies of the two countries... Read Biomarker detection gets 'sticky' US researchers have developed a fast and inexpensive protein biomarker detection device that could simplify disease diagnosis and aid in following disease progression in drug trials... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com